Trial intelligence / Profile preview

Immediate versus delayed intravenous oxytocin after amniotomy in labor augmentation

PACTR201803003123163Completed

Sponsor
Kenyatta National Hospital
Start
Feb 2018
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Randomised, open-label trial of oxytocin in labor dystocia (2 arms), sponsored by Kenyatta National Hospital. Primary endpoint: Amniotomy to delivery duration. Started Feb 2018; status: completed.

02

Drugs

oxytocin
03

Conditions

labor dystocia

Beyond the preview

Go deeper on PACTR201803003123163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201803003123163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call